Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer
Breast cancer is the most commonly diagnosed cancer type and the leading cause of cancer-related mortality in women worldwide. Breast cancer is fairly heterogeneous and reveals six molecular subtypes: luminal A, luminal B, HER2+, basal-like subtype (ER−, PR−, and HER2−), normal breast-like, and clau...
Main Authors: | Hsing-Ju Wu, Pei-Yi Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/2/636 |
Similar Items
-
Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer
by: Xiao-hong Mao, et al.
Published: (2021-01-01) -
Recent progress of prostate cancer biomarkers
by: Guo-Chen Zhao
Published: (2021-07-01) -
Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer
by: Tian Tian, et al.
Published: (2021-12-01) -
Association of Biomarker Discrepancy and Treatment Decision, Disease Outcome in Recurrent/Metastatic Breast Cancer Patients
by: Yujie Lu, et al.
Published: (2021-07-01) -
The Roles of CircRNAs in Bladder Cancer: Biomarkers, Tumorigenesis Drivers, and Therapeutic Targets
by: Fajuan Cheng, et al.
Published: (2021-07-01)